FR2914306B1 - OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES - Google Patents

OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES

Info

Publication number
FR2914306B1
FR2914306B1 FR0754202A FR0754202A FR2914306B1 FR 2914306 B1 FR2914306 B1 FR 2914306B1 FR 0754202 A FR0754202 A FR 0754202A FR 0754202 A FR0754202 A FR 0754202A FR 2914306 B1 FR2914306 B1 FR 2914306B1
Authority
FR
France
Prior art keywords
cyclodextrins
oligomers
vectors
active molecules
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0754202A
Other languages
French (fr)
Other versions
FR2914306A1 (en
Inventor
El Mustapha Belgsir
Pierre Ferchaud
Isabelle Opalinski
Frederic Turpin
Yves Cenatiempo
Jean Pierre Gesson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Poitiers
Biocydex SAS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Poitiers
Biocydex SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Poitiers, Biocydex SAS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0754202A priority Critical patent/FR2914306B1/en
Priority to PCT/FR2008/050567 priority patent/WO2008142316A1/en
Publication of FR2914306A1 publication Critical patent/FR2914306A1/en
Application granted granted Critical
Publication of FR2914306B1 publication Critical patent/FR2914306B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR0754202A 2007-04-02 2007-04-02 OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES Expired - Fee Related FR2914306B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0754202A FR2914306B1 (en) 2007-04-02 2007-04-02 OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES
PCT/FR2008/050567 WO2008142316A1 (en) 2007-04-02 2008-04-01 Cyclodextrine oligomers as vectors of activated molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0754202A FR2914306B1 (en) 2007-04-02 2007-04-02 OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES

Publications (2)

Publication Number Publication Date
FR2914306A1 FR2914306A1 (en) 2008-10-03
FR2914306B1 true FR2914306B1 (en) 2009-07-03

Family

ID=38657972

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0754202A Expired - Fee Related FR2914306B1 (en) 2007-04-02 2007-04-02 OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES

Country Status (2)

Country Link
FR (1) FR2914306B1 (en)
WO (1) WO2008142316A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
AU2006269940C1 (en) * 2005-07-18 2013-11-07 Seagen Inc. Beta-glucuronide-linker drug conjugates

Also Published As

Publication number Publication date
FR2914306A1 (en) 2008-10-03
WO2008142316A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
SMT201600216B (en) OCTAIDROPIRROL [3,4.C] PIRROLS DISTRIBUTED AS MODULATORS OF OREXINA RECEPTOR
BRPI0819828A2 (en) Process of synthesis of morpholino oligomers.
BRPI0914155A2 (en) shampoo preparations
ATE431152T1 (en) IMPROVED OPHTHAMOLOGICAL BIMATOPROST SOLUTION
DE112009004699A5 (en) Electrosurgical system
BRPI0821868A2 (en) Granule
BRPI0811579A2 (en) RECYCLED POLYMIDE MEMBRANES
BRPI0818373A2 (en) pelicetal compounds, synthesis and applications
BRPI0809659A2 (en) STROLLER
BRPI0923732A2 (en) "catalyst regeneration".
DK2201858T3 (en) Hair dryer
BRPI0821479A2 (en) Catalyst supported
BRPI0921299A2 (en) Adamantyl Benzamide Compounds
BRPI0810154A2 (en) TOOTHBRUSH
BRPI0914063A2 (en) concentrated shampoo composition
DE112008003934A5 (en) cosmetics mask
FI20086201A0 (en) Calculation of Nonlinearity Metrics
BRPI0923583A2 (en) synthesis of polymer conjugates of indocarbzole compounds.
DK2329319T3 (en) IMPROVED NANOIMPRINT PROCEDURE
FI20086154A0 (en) catalyst structure
BRPI0911613A2 (en) Hair care compositions.
BRPI0912399A2 (en) n- (2-amino-phenyl) -acrylamides
IT1391976B1 (en) PERFECT WHEEL STRUCTURE
BRPI0821234A2 (en) Process of preparation of purified pyrocathechol, and pyrocathechol.
FR2914306B1 (en) OLIGOMERS OF CYCLODEXTRINS, VECTORS OF ACTIVE MOLECULES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20161230